SEC 13F Intelligence

Boxer Capital Management, LLC / KYMR

Boxer Capital Management, LLC’s Kymera Therapeutics Inc Position

Does Boxer Capital Management, LLC own Kymera Therapeutics Inc (KYMR)? Yes — 329.1K shares worth $27M (+3.60% of its 13F portfolio) as of Q1 2026.

Position Value
$27M
Q1 2026
Shares
329.1K
% of Portfolio
+3.60%
Quarters Held
6
currently held

Position History KYMR

Reported value by quarter
Q4 ’24: $17MQ4 ’24Q1 ’25: $9MQ1 ’25Q2 ’25: $19MQ2 ’25Q3 ’25: $18MQ3 ’25Q4 ’25: $26MQ4 ’25Q1 ’26: $27MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026329.1K$27M+3.60%
Q4 2025329.1K$26M+5.60%
Q3 2025319.1K$18M+5.76%
Q2 2025432.0K$19M+9.49%
Q1 2025325.0K$9M+2.68%
Q4 2024425.0K$17M+1.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital Management, LLC’s full portfolio or all institutional holders of KYMR.